Skip to main content
logo
Klaria Pharma Holding AB (publ.) (FRA:6FN)
Germany flag Germany · Delayed Price · Currency is EUR
0.0648
-0.0016 (-2.41%)
Feb 20, 2026, 4:00 PM EST

FRA:6FN Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
8.992.258.455.87-
Other Revenue
----6.11
Revenue
8.992.258.455.876.11
Revenue Growth (YoY)
299.69%-73.41%44.07%-3.99%-15.35%
Gross Profit
8.992.258.455.876.11
Selling, General & Admin
14.1611.4315.9110.169.86
Research & Development
20.0622.1124.9551.3663.49
Other Operating Expenses
---0.21-0.213.74
Operating Expenses
34.2233.5340.6461.3187.09
Operating Income
-25.24-31.29-32.18-55.44-80.97
Interest Expense
-13.66-16.39-3.66-7.83-3.17
Interest & Investment Income
-0.010.0100
Currency Exchange Gain (Loss)
--0.040.02-0.380.06
Other Non Operating Income (Expenses)
0.01-0.03-0.02-0.0230.53
Pretax Income
-38.89-47.73-35.84-63.66-53.55
Income Tax Expense
-0.02-0.060.12-0.01
Earnings From Continuing Operations
-38.89-47.75-35.78-63.77-53.53
Net Income
-38.89-47.75-35.78-63.77-53.53
Net Income to Common
-38.89-47.75-35.78-63.77-53.53
Shares Outstanding (Basic)
1891251015852
Shares Outstanding (Diluted)
1891271015852
Shares Change (YoY)
49.19%25.62%73.49%12.15%19.58%
EPS (Basic)
-0.21-0.38-0.36-1.10-1.03
EPS (Diluted)
-0.21-0.38-0.36-1.10-1.03
Free Cash Flow
-35.04-11.91-9.06-49.77-24.8
Free Cash Flow Per Share
-0.18-0.09-0.09-0.86-0.48
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-280.88%-1391.68%-380.70%-944.79%-1324.82%
Profit Margin
-432.80%-2124.11%-423.28%-1086.81%-875.88%
Free Cash Flow Margin
-389.95%-529.67%-107.14%-848.18%-405.71%
EBITDA
-14.02-20.07-21.15-45.09-70.61
EBITDA Margin
-156.01%--250.14%--
D&A For EBITDA
11.2211.2211.0410.3510.37
EBIT
-25.24-31.29-32.18-55.44-80.97
EBIT Margin
-280.88%----
Revenue as Reported
9----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.